I feel your pain just like many involved as shareholders of this company over the long term. My goal is to point out the obvious and ensure a message is sent that the status quo is not acceptable anymore. It is obvious that they must control costs and bring a money partnership to fruition. They certainly can't go it alone. If they don't take this seriously then a case can be made that they are not meeting their responsibilities to cancer patients and their investors. Time is of the essence. I want nothing more than for them to be successful. I currently support them although I do not agree blindly with everything they do. I believe they have what they need to be successful. They simply need to manage the situation aggressively and leverage the value they have to strengthen the company and bring this biologic to success. It is very doable. They have made good decisions in the past. But that was in light of, in hindsight, a flawed strategy of going it alone. Now they need to follow the obvious and proper strategy to success for all. Cut costs until you can deliver a money partnership and right this ship. Everyone knows this at some level. Get it done. They can do it and we should expect nothing less.
Market Data 
Markets 
AI
